Summary of Nonclinical Data for Gene Therapy Developmental Candidate HMI-203 for Mucopolysaccharidosis Type II (MPS II), or Hunter Syndrome.

Smith L, Patel K, Seabrook T, et al. WORLDSymposium 2022.